Abstract B129: DUP5, a novel mRNA translation inhibitor as a payload for antibody drug conjugates, exhibits promising preclinical efficacy
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Shengchao Lin, Bing Li, Yu Zhang, Jun Yao, Liwen Liang, Yang Xu, Rong Shi, Zhongyuan Zhu, Yang Qiu, Haiqing Hua
Institution: Duality Biotherapeutics, Inc. (China)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444512
Cites:
Cited by:
Related to: